Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphopenia”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Early research (Phase 1)Study completedNCT00626483
What this trial is testing

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Who this might be right for
Malignant Neoplasms Brain
Gary Archer Ph.D. 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07267234
What this trial is testing

PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)

Who this might be right for
Solid CancerLymphopeniaRadiotherapy+1 more
Second Affiliated Hospital of Soochow University 65
Not applicableStudy completedNCT02698683
What this trial is testing

Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Patients

Who this might be right for
Lymphopenia
University of Sao Paulo 14
Testing effectiveness (Phase 2)Ended earlyNCT04426201
What this trial is testing

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

Who this might be right for
COVID-19Lymphocytopenia
Revimmune 10
Very early researchStudy completedNCT04781309
What this trial is testing

NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy

Who this might be right for
Progressive Multifocal Leukoencephalopathy
National Institute of Neurological Disorders and Stroke (NINDS) 12
Early research (Phase 1)Ended earlyNCT02659800
What this trial is testing

Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas

Who this might be right for
LymphopeniaMalignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Testing effectiveness (Phase 2)Study completedNCT02640807
What this trial is testing

IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients

Who this might be right for
Severe Sepsis With Septic Shock
Revimmune 27
Not applicableStudy completedNCT00086476
What this trial is testing

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Who this might be right for
Blood Coagulation Disorders
National Human Genome Research Institute (NHGRI) 3
Not applicableStudy completedNCT06368349
What this trial is testing

Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma

Who this might be right for
Lymphopenia
Chang Gung Memorial Hospital 190
Testing effectiveness (Phase 2)Looking for participantsNCT06584006
What this trial is testing

Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors

Who this might be right for
Hematological MalignancyLymphocytopenia
The First Affiliated Hospital of Xiamen University 50
Not applicableStudy completedNCT03549546
What this trial is testing

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.

Who this might be right for
Lung CancerSurgery
Centre Hospitalier Universitaire de Saint Etienne 31
Early research (Phase 1)Study completedNCT00693095
What this trial is testing

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer

Who this might be right for
Glioblastoma
John Sampson 23
Large-scale testing (Phase 3)Study completedNCT00278954
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.

Who this might be right for
Primary ImmunodeficiencyCommon Variable HypogammaglobulinemiaX-linked Hypogammaglobulinemia+3 more
Bio Products Laboratory 50
Testing effectiveness (Phase 2)UnknownNCT04371939
What this trial is testing

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Not applicableStudy completedNCT00845416
What this trial is testing

Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population

Who this might be right for
Severe Combined ImmunodeficiencyT Cell Lymphocytopenia
University of California, San Francisco 1,800
Testing effectiveness (Phase 2)Study completedNCT04578210
What this trial is testing

Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia

Who this might be right for
Corona Virus Infection
Instituto de Investigación Hospital Universitario La Paz 84
Not applicableLooking for participantsNCT03394053
What this trial is testing

The Mechanistic Biology of Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 2,500
Testing effectiveness (Phase 2)UnknownNCT03019809
What this trial is testing

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Who this might be right for
Wiskott-Aldrich SyndromeHematopoietic Stem Cell TransplantationGraft Failure
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Not applicableUnknownNCT03198195
What this trial is testing

Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome
Capital Research Institute of Pediatrics 5
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Load More Results